HMGB1 and injury: In vivo, HMGB1 can initiate systemic inflammation that can be associated with fever, epithelial barrier dysfunction, endothelial cell activation, acute lung injury, anemia, cognitive dysfunction, arthritis, anorexia and even death [77,78,163].